Ligand Pharmaceuticals saw the highest growth of 5.99% in patent filings in May and 1.99% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw no growth in patent filings and grants by 1.99%. GlobalData’s DataBook provides a comprehensive analysis of Ligand Pharmaceuticals‘s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Ligand Pharmaceuticals has been focused on protecting inventions in European Patent Office(EPO) with five publications in Q2 2024
The European Patent Office(EPO) Patent Office dominates the patent filings and grants with nearly 25% filings and 20% grants. The European Patent Office(EPO), United States(US), Australia(AU), and Colombia(CO) patent Office are among the top ten patent offices where Ligand Pharmaceuticals is filings its patents. Among the top granted patent authorities, Ligand Pharmaceuticals has 60% of its grants in United States(US) and 20% in European Patent Office(EPO).
Axsome Therapeutics and Sage Therapeutics could be the strongest competitors for Ligand Pharmaceuticals
Ligand Pharmaceuticals stands in second position with respect to its patent publications among its competitors.
Patents related to addiction and novel proteins lead Ligand Pharmaceuticals's portfolio
Ligand Pharmaceuticals has the highest number of patents in addiction followed by, novel proteins and plant-based diets. For addiction, nearly 33% of patents were filed and no patents were granted in Q2 2024.
Diabetes related patents lead Ligand Pharmaceuticals portfolio followed by hyperlipidemia, and liver cancer
Ligand Pharmaceuticals has highest number of patents in diabetes followed by hyperlipidemia, liver cancer, cardiovascular disease, and atherosclerosis. For diabetes, nearly 3% of patents were filed and 6% of patents were granted in Q2 2024.
For comprehensive analysis of Ligand Pharmaceuticals's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
